Majid Moshirfar1,2,3, Anisha N Somani4, Mahsaw N Motlagh5, Yasmyne C Ronquillo3. 1. Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah School of Medicine, Salt Lake. 2. Utah Lions Eye Bank, Murray. 3. Hoopes Durrie Rivera Research Center, Hoopes Vision, Draper, Utah. 4. McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, Texas. 5. The University of Arizona College of Medicine-Tucson, Tucson, Arizona, USA.
Abstract
PURPOSE OF REVIEW: This review aims to cover the preoperative planning, intraoperative considerations, and postoperative management that aids in successful outcomes of patients with cataract and uveitis. Disease-specific management and pediatric management will also be addressed. RECENT FINDINGS: Dexamethasone implants appear to be a safe and effective addition to standard steroid treatment in decreasing the incidence of postoperative cystoid macular edema (CME). Intravitreal steroids and topical difluprednate have shown utility in CME treatment. SUMMARY: Cataract surgery in eyes with uveitis is generally safe and effective if inflammation is well controlled; however, complication rates are still higher than in eyes without uveitis. Future investigations should delineate outcomes for eyes with different etiologies of uveitis, and further research is needed to adequately control inflammation and avoid postoperative complications.
PURPOSE OF REVIEW: This review aims to cover the preoperative planning, intraoperative considerations, and postoperative management that aids in successful outcomes of patients with cataract and uveitis. Disease-specific management and pediatric management will also be addressed. RECENT FINDINGS:Dexamethasone implants appear to be a safe and effective addition to standard steroid treatment in decreasing the incidence of postoperative cystoid macular edema (CME). Intravitreal steroids and topical difluprednate have shown utility in CME treatment. SUMMARY:Cataract surgery in eyes with uveitis is generally safe and effective if inflammation is well controlled; however, complication rates are still higher than in eyes without uveitis. Future investigations should delineate outcomes for eyes with different etiologies of uveitis, and further research is needed to adequately control inflammation and avoid postoperative complications.
Authors: Anne von Mässenhausen; Nadia Zamora Gonzalez; Francesca Maremonti; Alexia Belavgeni; Wulf Tonnus; Claudia Meyer; Kristina Beer; Monica T Hannani; Arthur Lau; Mirko Peitzsch; Paul Hoppenz; Sophie Locke; Triantafyllos Chavakis; Rafael Kramann; Daniel A Muruve; Christian Hugo; Stefan R Bornstein; Andreas Linkermann Journal: Sci Adv Date: 2022-02-02 Impact factor: 14.136